Compare Nike Inc (NKE) vs Nutrien Ltd (NTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nike Inc vs Nutrien Ltd — how do they compare? Nike Inc trades at $34.71 (market cap $51.60B), while Nutrien Ltd trades at $67.48 (market cap $33.31B). The key difference: Nike Inc is the larger of the two by market cap, and Nike Inc pays the higher dividend (4.72%). Which is the better fit depends on your goals — on Pluang, investors hold Nike Inc for 155 Days and Nutrien Ltd for 59 Days on average.
| NKE | NTR | |
|---|---|---|
Market Cap | $51.60B | $33.31B |
Volume | 43,506,062 | 1,330,729 |
Sector | Consumer Cyclical | Basic Materials |
52-Week High | $69.68 | $83.94 |
52-Week Low | $33.87 | $53.64 |
Typical Hold Time | 155 Days | 59 Days |
Enterprise Value | $54.30B | $45.11B |
Dividend Yield | 4.72% | 3.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nike (NKE) trades at $34.74, up 1.11% with bearish technical signals despite recent earnings beats. The company faces revenue pressure with FY2025 sales declining to $46.31B and net margin compressing to 6.74%. Analyst consensus remains positive with a $36.98 price target, though technical indicators show 16 sell signals against 2 buy signals. Recent news highlights challenges in China and EMEA markets while emphasizing Nike's strong brand positioning.
Nike's investment case balances strong brand equity against near-term operational headwinds. The stock offers value at 16.62 P/E with 21.56% ROE, but investors face risks from sluggish consumer demand and margin pressure. The upcoming Q4 2026 earnings on June 30 will be critical for confirming turnaround progress.
Nutrien (NTR) trades at $69.87, down 0.14% with bearish technical signals despite recent earnings beats. The company shows improving fundamentals with Q1 2026 EPS beating expectations at $0.51 versus $0.48, though Q2 2026 missed at $2.61. Revenue trends show recovery from $26.0B in 2024 to $26.9B in 2025, with net income margin improving to 8.44%. Recent news highlights mixed sentiment with stock volatility following geopolitical fertilizer developments.
The outlook remains cautiously optimistic with analyst consensus at $76.14 target (8.9% upside) and 60.6% buy ratings. Key opportunities include strong potash demand and cost discipline, while risks involve fertilizer price volatility and competitive pressures from potential Belarus deals. Cash flow trends show consistent operational strength despite negative net flows.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nike Inc
NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.
Read more on NKE →About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →
